Pharmanex v. Shalala
This article was originally published in The Tan Sheet
Executive Summary
Oral arguments are scheduled for May 10 before a Denver federal appeals court on whether Cholestin may be marketed as a dietary supplement. FDA is appealing a Salt Lake City federal judge's decision reversing the agency's determination the red yeast rice supplement containing lovastatin, the same ingredient in Merck's cholesterol-reducer Mevacor, is a drug